Suzana Sturlini Couto

Title: Suzana Sturlini Couto: Innovator in Cancer Treatment

Introduction

Suzana Sturlini Couto is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 3 patents, her work focuses on improving drug efficacy and screening compounds for various diseases.

Latest Patents

Couto's latest patents include "Methods for screening cereblon modifying compounds" and "Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers." The first patent outlines a method for screening cereblon modifying compounds to treat diseases by assessing the degradation of the SALL protein. The second patent provides methods for using cereblon-associated proteins as biomarkers to predict and monitor therapeutic responses in patients with various cancers.

Career Highlights

Suzana Sturlini Couto is currently associated with Celgene Corporation, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of cancer treatment and improving patient outcomes.

Collaborations

Couto has collaborated with notable colleagues, including Matthew William Burnell Trotter and Patrick Hagner, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Suzana Sturlini Couto's innovative contributions to cancer treatment through her patented methods highlight her dedication to improving healthcare. Her work continues to inspire advancements in the medical field and offers hope for patients facing challenging diseases.